A Cancer Vaccine
Designed Around
Your Tumor.
Explore personalized cancer vaccine programs and clinical trials in the U.S., matched to your diagnosis and molecular profile.
Built Around the Biology
of Your Cancer.
Personalized cancer vaccines use unique tumor-specific targets—often called neoantigens—to help the immune system recognize and attack cancer cells.
What Are Cancer Vaccines?
Cancer vaccines are designed to help your immune system recognize and fight cancer cells.
They are not all the same. Here are the main types patients should know about:
Preventive Cancer Vaccines
Work like traditional vaccines, preventing certain cancers before they develop.
Example: HPV vaccine to prevent cervical cancer.
Off-the-Shelf Cancer Vaccines
Standardized vaccines developed to target shared cancer markers. They can help some patients, but are not tailored to an individual's tumor profile.
Personalized Cancer Vaccines
Created using the genetic and molecular profile of your tumor. These vaccines are unique to you—designed to train your immune system to recognize and destroy your specific cancer cells.
Among these, personalized cancer vaccines represent the most advanced and targeted approach—offering new hope for patients worldwide. In the next section, we'll explore the key benefits.
From Your Tumor.
To a Treatment Designed for You.
A precision process that turns the unique biology of your cancer into a personalized immune response.
TUMOR SAMPLE
A sample of your tumor is collected to analyze its unique molecular characteristics.
GENOMIC SEQUENCING
Advanced sequencing identifies the unique mutations and neoantigens present in your cancer.
TARGET IDENTIFICATION
Bioinformatics and AI pinpoint the most promising neoantigen targets that can trigger a strong immune response.
VACCINE DESIGN
A personalized vaccine is designed to train your immune system to recognize and attack cancer cells with precision.
TREATMENT & MONITORING
The vaccine is administered and your response is continuously monitored to guide personalized care.
That's the power of a personalized cancer vaccine.
Could a Personalized
Cancer Vaccine Be Relevant to Your Case?
Eligibility for personalized cancer vaccine programs and clinical trials depends on several factors, including cancer type, stage, prior treatment, tumor tissue availability, molecular characteristics, and individual trial or program criteria.
SOLID TUMORS
Including lung, breast, melanoma, ovarian, colorectal, pancreatic, glioblastoma and other solid cancers.
ADVANCED OR TREATMENT-RESISTANT CANCERS
For patients who have explored standard options or are seeking additional approaches.
MOLECULAR OR GENETICALLY DEFINED CANCERS
When specific tumor mutations or biomarkers can be identified.
MINIMAL RESIDUAL DISEASE (MRD) OR EARLY STAGE
In select cases, as part of emerging research strategies.
CLINICAL TRIAL PARTICIPANTS
For those who may qualify for ongoing vaccine trials in the U.S. and worldwide.
PATIENTS WITH AVAILABLE TUMOR TISSUE
Adequate tumor samples help enable vaccine development and analysis.
Explore Leading U.S.
Cancer Vaccine Programs
Personalized cancer vaccine research is advancing across leading U.S. cancer centers. MediPocket helps identify programs relevant to your diagnosis, molecular profile, and eligibility.
Investigating personalized cancer vaccines across multiple tumor types and earlier stages of disease.
Pioneering neoantigen vaccine research and combination strategies in immunotherapy.
Advancing vaccine platforms with a focus on precision medicine and immune response.
Developing next-generation vaccines and cellular immunotherapy approaches.
Exploring individualized vaccines through cutting-edge immunology and translational research.
Driving innovation in cancer vaccines and personalized immune therapeutics.
Advanced Science.
A Clearer Path to Access.
We combine the power of cutting-edge science with personalized navigation —
so you can focus on what matters most:
your health, your choices, your future.
Physician-Led Case Review
Your case is reviewed by our physician team to understand your diagnosis, treatment history, and molecular profile in detail.
Molecular & Program Matching
We analyze your tumor biology and match you with the most relevant cancer vaccine programs and clinical trials in the U.S.
U.S. Specialist & Research Navigation
We connect you with leading U.S. specialists and research centers and guide you through every step of evaluation and enrollment.
One Dedicated Care Navigator
You'll have one dedicated navigator who manages your journey with clarity, coordination, and complete confidentiality.
From complex science to clear next steps — we simplify the journey
so you never have to navigate it alone.
Real Journeys. Real Impact.
Every case is unique, but the goal is the same—access to the right expertise, the right treatment, and the right outcomes.
MediPocket connected us with a leading U.S. specialist for a second opinion that changed our treatment path completely.
OVARIAN CANCER
The clinical trial matched through MediPocket gave my father access to an innovative therapy not available locally.
LUNG CANCER
From visa support to hospital coordination, everything was seamless. We felt truly cared for.
COLORECTAL CANCER
The team helped us navigate complex options and find the best path forward with confidence and clarity.
BREAST CANCER
Patient experiences shared with permission. Individual results may vary.
Answers to the Questions
That Matter Most.
Personalized cancer vaccines are an evolving area of research and clinical innovation.
Here are the most common questions patients and families ask.
Who may be eligible for a personalized cancer vaccine?
Eligibility depends on cancer type, stage, prior treatment, tumor tissue availability, molecular characteristics, and specific program criteria.
What types of cancers are these vaccines being studied for?
Research is ongoing across multiple solid tumors and certain blood cancers. Eligibility varies by program and individual case.
Are personalized cancer vaccines FDA approved?
Most personalized cancer vaccines are investigational and available only through clinical trials or research programs.
Are these vaccines available through clinical trials?
Yes. Many programs are offered within clinical trials or early access research protocols at leading U.S. cancer centers.
Will I need tumor tissue or genomic testing?
In most cases, yes. Tumor tissue and genomic/molecular profiling are typically required to design and evaluate a personalized vaccine.
Can international patients access these programs in the U.S.?
Yes. Many U.S. research centers welcome international patients. We assist with evaluation, travel planning, and care coordination.
What is the typical timeline?
Timelines vary by program and case. From initial review to treatment, it can range from a few weeks to several months.
What are the costs involved?
Costs vary by program, testing, and treatment plan. We provide clear cost estimates before you decide to move forward.
What medical records do I need to share?
We typically need pathology reports, imaging, treatment history, and any genomic or molecular testing you may have.
What is MediPocket's exact role?
We are your independent care navigation partner—evaluating your case, identifying relevant programs, coordinating with top U.S. centers, and supporting you at every step.
Have more questions about your specific case?
Our team is here to help you explore the right options.
Could a Personalized
Cancer Vaccine
Be an Option for You?
Cutting-edge science. World-class research.
The right access can change everything.
Our team will personally review your case and identify the most relevant U.S. specialists, research programs and clinical trial pathways that may be right for you.
You focus on what matters most.
We'll navigate the complexity.
Independent guidance. Global expertise.
Personalized for you.
Request a Personalized
Cancer Vaccine Case Review
Share a few details about your diagnosis and treatment history.
Our team will take it from there.